Varicose Vein Treatment

Global Varicose Vein Treatment Market to Reach US$1.7 Billion by 2030

The global market for Varicose Vein Treatment estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Sclerotherapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Endovenous Ablation segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$350.5 Million While China is Forecast to Grow at 7.3% CAGR

The Varicose Vein Treatment market in the U.S. is estimated at US$350.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$376.4 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Varicose Vein Treatment Market - Key Trends & Drivers Summarized

What Is Driving the Demand for Varicose Vein Treatment?

The demand for varicose vein treatment has surged as an increasing number of individuals seek effective solutions for this common vascular condition. Varicose veins, characterized by swollen, twisted veins, often cause discomfort and aesthetic concerns, leading to a growing preference for minimally invasive treatment options. With advancements in medical technology, treatments such as endovenous laser therapy (EVLT), sclerotherapy, and radiofrequency ablation have gained popularity due to their effectiveness, shorter recovery times, and reduced risk of complications. The rising awareness of varicose veins and the availability of advanced treatment methods are key factors driving the market`s growth, especially as more people seek to improve both their health and cosmetic appearance.

How Are Technological Advancements Impacting Varicose Vein Treatment?

Technological advancements have revolutionized the varicose vein treatment market, offering more efficient and patient-friendly procedures. The introduction of innovative laser and radiofrequency devices has significantly improved the precision and safety of treatments, reducing the need for invasive surgeries. These advancements have also made it possible to treat varicose veins in outpatient settings, enhancing patient convenience. Additionally, the development of new sclerosing agents used in sclerotherapy has expanded the range of treatable cases, allowing for more effective and lasting results. The integration of ultrasound guidance in these procedures has further improved outcomes, making it easier for practitioners to locate and treat affected veins accurately.

What Are the Emerging Trends in Varicose Vein Treatment?

The varicose vein treatment market is witnessing several emerging trends that are shaping its future. One notable trend is the growing preference for non-thermal, non-tumescent methods, such as mechanochemical ablation and cyanoacrylate glue, which offer effective treatment options with fewer side effects. Additionally, the increasing demand for aesthetic procedures, particularly among younger populations, is driving the adoption of varicose vein treatments for cosmetic purposes. Another trend is the expansion of treatment options to include preventive measures, such as lifestyle interventions and compression therapy, aimed at managing symptoms and preventing the progression of varicose veins. The market is also seeing a rise in the use of telemedicine and remote consultations, which are making varicose vein treatment more accessible to patients in remote or underserved areas.

What Factors Are Driving the Growth of the Varicose Vein Treatment Market?

The growth in the varicose vein treatment market is driven by several factors, including the rising prevalence of venous diseases, particularly among aging populations and those with sedentary lifestyles. The increasing awareness of the health risks associated with untreated varicose veins, such as deep vein thrombosis (DVT) and chronic venous insufficiency (CVI), is encouraging more individuals to seek treatment. The growing demand for minimally invasive procedures, which offer quicker recovery and fewer complications, is also propelling market growth. Furthermore, advancements in treatment technologies, along with the rising availability of specialized clinics and skilled practitioners, are making varicose vein treatments more accessible and appealing to a broader patient base. The aesthetic benefits of these treatments, coupled with the rise in disposable incomes and health consciousness, are also contributing to the market`s expansion.

SCOPE OF STUDY:

The report analyzes the Varicose Vein Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Procedure (Sclerotherapy, Endovenous Ablation, Surgical Ligation & Stripping); Product (Sclerotherapy Injection, Ablation Devices, Other Products); End-Use (Hospitals, Specialized Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 46 Featured) -

• AngioDynamics, Inc.
• biolitec AG
• BTG PLC
• Dornier MedTech GmbH
• Energist Group
• Eufoton s.r.l.
• Fotona d.o.o.
• Lumenis Ltd.
• Medtronic PLC
• Merz Aesthetics
• Quanta System SpA
• Sciton, Inc.
• Syneron Medical Ltd.
• Vascular Solutions, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.